A method of fit testing includes providing a respirator; providing a sensor having a sensing element removably positioned substantially within an interior gas space of the respirator; providing a reader configured to be in wireless communication with the sensor; positioning the respirator over a mouth and a nose of a user while the sensor is positioned substantially within an interior gas space of the respirator; and observing respirator fit assessment data communicated from the sensor to the reader.

Disclosed herein are an apparatus for electrically assessing and/or manipulating cells. One aspect is directed to electrically mapping cells on the surface of the semiconductor substrate via cross-electrode impedance measurements. Further according to some aspects, the electrode array allows for spatially addressable electrical stimulation and/or recording of electrical signals in real-time using the CMOS circuitry. Some of these aspects are directed to using an electrode array to perform cell patterning through electrochemical gas generation, and extracellular electrochemical mapping.

A uniformity property acquisition apparatus is the uniformity property acquisition apparatus configured to acquires a uniformity property of a mixture in which an insoluble solid matter is mixed in liquid, and the uniformity property acquisition apparatus includes: a pair of electrodes configured to apply the AC signal to the mixture; measurement unit configured to measure impedance of the mixture on the basis of a response signal flowing through the mixture when the AC signal is applied to the mixture; and processing unit configured to acquire the uniformity property of the mixture on the basis of the impedance measured by the measurement unit.

The inventive concept relates to a body composition analysis system. A body composition analysis system according to an embodiment of the inventive concept includes a sinusoidal signal generator, a synchronous detector, and a bioimpedance analyzer. The sinusoidal signal generator converts a digital sinusoidal signal having a target frequency into an analog sinusoidal signal. The synchronous detector extracts a target frequency component of a bioelectrical signal generated in response to an analog sinusoidal signal based on the digital sinusoidal signal. The bioimpedance analyzer calculates the bioimpedance based on the target frequency component of the bioelectrical signal. According to the inventive concept, it is possible to improve the selectivity for extracting the target frequency component of the bioelectrical signal and to reduce the area and variations of characteristics for the implementation of the integrated circuit.

A system includes a slurry pipe and a pipe liner disposed within an inner diameter of the slurry pipe. At least one redundant transducer wear ladder sensor is disposed within the pipe liner. A computer controller is operatively coupled to the at least one redundant transducer wear ladder sensor via a flexible ribbon cable. A radio-wave transmitter is operatively coupled to the computer controller. A radio-wave receiver is operatively coupled to the computer controller. A power source is operatively coupled to the radio-wave transmitter and to the radio-wave receiver.

Disclosed is a method for diagnosis of a two-conductor field instrument and a corresponding two-conductor field instrument. In a normal operating mode, an input voltage is provided and an output current is output. In a diagnostic operating mode, the method includes: providing a first diagnosis-input voltage and outputting a first diagnosis-output current during a first time interval, providing a second diagnosis-input voltage and outputting a second diagnosis-output current during a second time interval, determining the second time interval from the first time interval, registering a first and second diagnosis-output voltage as a function of the first and second diagnosis-output current, and checking the functionality of the two-conductor field instrument by the first and second diagnosis-input voltage, the first and second time interval, the first and second diagnosis-output electrical current, the first and second diagnosis-output voltage based on the input voltage and/or based on the output electrical current.

A multi-analyte sensor device is disclosed. The multi-analyte device is a handheld device that includes a replaceable sensor. In one embodiment, the replaceable sensor includes a plurality of electrodes coated with one or more different molecular imprinted polymer (MIP) coatings for measuring concentrations of target analytes. The replaceable sensor is configured to be attached or detached from the device one or more times.

The present invention provides a circuit applied to a bio-information acquisition system, wherein the circuit includes a terminal, an output circuit, a feedback circuit and a calibration circuit. In the operations of the circuit, the terminal is arranged to receive an input signal, the output circuit is configured to generate an output signal according to the input signal, the feedback circuit is configured to receive the output signal to generate a current signal to the terminal, and the calibration circuit is configured to generate a control signal to control the feedback circuit to determine a level of the current signal according to the output signal.

The claimed invention is an apparatus and method for performing impedance spectroscopy with a handheld measuring device. Conformal analyte sensor circuits comprising a porous nanotextured substrate and a conductive material situated on the top surface of the solid substrate in a circuit design may be used alone or in combination with a handheld potentiometer. Also disclosed are methods of detecting and/or quantifying target analytes in a sample using a handheld measuring device.

The present invention relates to a fatty liver and liver fibrosis evaluation system based on impedance. The fatty liver and liver fibrosis evaluation system based on impedance provided in one aspect of the present invention uses 3-dimensional liver microtissues so that the fatty liver formation and the stiffness changes resulted from liver fibrosis induced by a test drug can be analyzed with non-invasive and highly reproducible manner.